This study investigates the photocatalytic degradation of amoxicillin (AMO) by simulated solar irradiation using WO
3
as a catalyst. A three-factor-three-level Box-Behnken design (BBD) consisting of 30 experimental runs is employed with three independent variables: initial AMO concentration, catalyst dosage, and pH. The experimental results are analyzed in terms of AMO degradation and mineralization, the latter of which is measured using dissolved organic carbon (DOC). The results show that the photocatalytic degradation of AMO follows pseudo-first-order kinetics. AMO degradation efficiency and the pseudo-first-order rate constants decrease with increasing initial AMO concentration and pH and increase with increasing catalyst dosage. Though AMO degradation is almost fully complete under the experimental conditions, DOC removal is much lower; the highest DOC removal rate is 35.82% after 180 min. Using these experimental results, second-order polynomial response surface models for AMO and DOC removal are constructed. In the AMO removal model, the first-order terms are the most significant contributors to the prediction, followed by the quadratic and interaction terms. Initial AMO concentration and pH have a significant negative impact on the photocatalytic degradation of AMO, while catalyst dosage has a significant positive impact. In contrast, in the DOC removal model, the quadratic terms make the most significant contribution to the prediction and the first-order terms the least. The optimal conditions for the photocatalytic degradation of AMO are found to be an initial AMO concentration of 1.0 μM, a catalyst dosage of 0.104 g/L, and a pH of 4, under which almost complete removal of AMO is achieved (99.99%).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.